EUVIMEDEUVIMED entdecken
Open Access

Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder.

Rafaela M Fontes iD, Ana Carolina L Bovo, Roberta Freitas-Lemos, Warren K Bickel iD

Experimental and Clinical Psychopharmacology · 2025-06 · 33 (3) · 291-299

DOI: 10.1037/pha0000769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2025-06. Verfasst von Rafaela M Fontes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fralin Biomedical Research Institute, Virginia Tech Carilion. Hauptthemen laut MEDLINE: Substance-Related Disorders, Delay Discounting. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Virginia Tech Carilion; Fralin Biomedical Research Institute, NCI NIH HHS, National Institutes of Health; National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with substance use disorder (SUD) show consistently higher delay discounting (DD) rates than controls for both future and past outcomes, as well as for gains and losses. However, differences in these DD effects (e.g., tense and sign) among individuals in SUD recovery have yet to be explored. Therefore, the goal of the present study was to (a) investigate differences in discounting of past and future gains and losses among individuals in SUD recovery and (b) examine differences in these DD effects between individuals in different stages of remission (i.e., not in remission, in early remission, or in sustained remission). Our results indicate that individuals in recovery discount past and future gains, but not losses, symmetrically. Additionally, individuals in recovery discount gains more than losses (i.e., sign effect) for the future but not for the past. Finally, those in sustained remission showed significantly lower DD rates than those not in remission, regardless of the DD task. Thus, other discounting tasks might provide a similarly accurate measure of DD and can be employed to assess differences in discounting between those in remission and those not in remission. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersDelay DiscountingHumansMaleFemaleAdultYoung AdultMiddle AgedReward

Autor:innen und Institutionen

  • Fralin Biomedical Research Institute, Virginia Tech Carilion.

ORCID-Profile: Rafaela M Fontes, Warren K Bickel

Förderung

  • Virginia Tech Carilion; Fralin Biomedical Research Institute
  • NCI NIH HHS
  • National Institutes of Health; National Institute on Drug Abuse
  • NIDA NIH HHS
  • National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
  • NIAAA NIH HHS
  • National Institutes of Health
  • Virginia Tech Carilion

Zitieren

APA

Fontes, R. M., Bovo, A. C. L., Freitas-Lemos, R., & Bickel, W. K. (2025). Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder. Experimental and Clinical Psychopharmacology, 33(3), 291-299. https://doi.org/10.1037/pha0000769

Vancouver

Fontes RM, Bovo ACL, Freitas-Lemos R, Bickel WK. Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder. Experimental and Clinical Psychopharmacology. 2025;33(3):291-299. doi:10.1037/pha0000769

BibTeX
@article{Fontes2025,
  author = {Fontes, Rafaela M and Bovo, Ana Carolina L and Freitas-Lemos, Roberta and Bickel, Warren K},
  title = {Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {291--299},
  doi = {10.1037/pha0000769}
}
Kostenlos starten →